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Abstract
BACKGROUND—Gamma-aminobutyric acid (GABA), the brain’s principal inhibitory 
neurotransmitter, has been associated with perceptual and attentional functioning. Recent 
application of magnetic resonance spectroscopy (MRS) provides in vivo evidence for decreasing 
GABA concentrations during adulthood. It is unclear, however, how age-related decrements in 
cerebral GABA concentrations contribute to cognitive decline, or whether previously reported 
declines in cerebral GABA concentrations persist during healthy aging. We hypothesized that 
participants with higher GABA concentrations in the frontal cortex would exhibit superior 
cognitive function and that previously reported age-related decreases in cortical GABA 
concentrations continue into old age.
METHODS—We measured GABA concentrations in frontal and posterior midline cerebral 
regions using a Mescher-Garwood point-resolved spectroscopy (MEGA-PRESS) 1H-MRS 
approach in 94 older adults without history or clinical evidence of mild cognitive impairment or 
dementia (mean age, 73 years). We administered the Montreal Cognitive Assessment to assess 
cognitive functioning.
RESULTS—Greater frontal GABA concentrations were associated with superior cognitive 
performance. This relation remained significant after controlling for age, years of education, and 
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brain atrophy. GABA concentrations in both frontal and posterior regions decreased as a function 
of age.
CONCLUSIONS—These novel findings from a large, healthy, older population indicate that 
cognitive function is sensitive to cerebral GABA concentrations in the frontal cortex, and GABA 
concentration in frontal and posterior regions continue to decline in later age. These effects 
suggest that proton MRS may provide a clinically useful method for the assessment of normal and 
abnormal age-related cognitive changes and the associated physiological contributors.
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Gamma-aminobutyric acid (GABA) is the principal inhibitory neurotransmitter in the human 
nervous system and plays a fundamental role in central nervous system function (1). GABA 
neurotransmission is involved in nearly all neuronal coding and processing throughout the 
brain. It directly influences membrane potentials through ionic GABAA receptors and 
modulates both short- and longer-term neuronal activity via G-protein coupled GABAB 
receptors, modifying synaptic and network plasticity (2–6). Given this connection to 
synaptic plasticity, GABA has been studied in the context of the aging brain. Recent work 
demonstrates that GABA concentrations decline with age (7), and rodent models have 
shown age-related decreases in a GABA synthetic enzyme, glutamic acid decarboxylase (8). 
However, the relation between these long-term decreases in GABA concentrations and age-
related declines in cognitive function has yet to be determined.
A large body of GABA studies relies on examination of downstream pharmacological 
effects of GABAergic agents (e.g., benzodiazepines) and animal models. This work links 
GABA to age-related cognitive decline in rodents (9), specifically noting the importance of 
GABA as a modulator of memory encoding (10,11). Although such studies provide a strong 
foundation for investigations into the relation between GABA and cognition, these methods 
make extensions of their results to more broad discussions of human cognition challenging. 
Relevant to the question at hand, then, is the development of Mescher-Garwood point-
resolved spectroscopy (MEGA-PRESS) (12,13) for GABA-edited magnetic resonance 
spectroscopy (MRS) (12,14,15). This acquisition sequence allows for relatively rapid and 
reliable quantification of GABA concentrations in the brain of awake humans. Because these 
GABA concentrations are experimentally mutable (16,17), MEGA-PRESS more directly 
enables research into the regionally variable role of GABA in behavior and cognitive 
function.
This approach has proven to be a flexible and powerful tool for examining GABA, 
facilitating investigations of GABAergic contributions to specific behaviors and pathological 
disorders and differences in GABA concentrations between populations. Broadly, 
researchers have used this approach to demonstrate that GABA concentrations correlate with 
other measures of brain activity, including functional magnetic resonance imaging indices 
(18,19), cerebral blood flow (19), and motor cortex gamma oscillations (20). Specifically 
applying this work to the intersection between GABA and cognition, several MRS studies 
have examined the role of GABA in sensory and motor functioning in healthy populations. 
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Often, these studies delineate the differential importance of GABA in various brain regions 
for multiple sensorimotor or cognitive functions. For example, associations between 
sensorimotor GABA concentrations and tactile sensitivity have been demonstrated in 
sensorimotor cortices (21,22). GABA concentrations in the occipital cortex have been shown 
to relate to visual orientation discrimination (23), whereas frontal GABA concentrations 
correspond with working memory performance (24). Thus, some degree of specificity 
between cortical GABA concentration and cognitive ability seems likely. Less clear, 
however, is the relation between GABA and higher-order cognitive functioning and its 
decline in healthy aging.
Notably, although GABA concentrations tend to be stable over the short term (25), they do 
change over longer periods of time. A recent cross-sectional study of adults (20–76 years of 
age) indicated that GABA concentrations decrease with age after adolescence. This report 
specifically found an approximate 5% reduction in GABA concentrations with age per 
decade in the frontal cortex (7). Because the frontal cortex is important for numerous 
cognitive domains, notably those related to executive function (26–29), such a decline might 
correlate or even underlie alterations in related domains of cognitive function. The 
functional significance of these age-associated changes in GABA is not well established.
Given these considerations, the present study examined the relation between frontal and 
posterior GABA concentrations and cognitive function in the context of normal cognitive 
aging. We sought to extend previous work relating GABA and cognitive function in 
modality-specific cortices (e.g., occipital lobe) by investigating higher-order cognition with a 
general cognitive screening measure, the Montreal Cognitive Assessment (MoCA) (30). This 
tool, widely used in clinical settings, taps several cognitive domains, including attention/
working memory, verbal memory, naming, and fluency. Because a number of these domains 
fall under the umbrella of executive functions, the MoCA is quite sensitive to frontal 
dysfunction in general (31). Convergently, older adults demonstrate changes in both frontal 
activation and frontally mediated cognitive functions. Thus, we placed our primary MRS 
voxel of interest in the frontal lobe. We predicted that GABA concentrations would continue 
to decrease in advanced age. We also predicted that the relation between concentrations of 
GABA in the frontal regions would predict general cognitive performance on the MoCA. We 
additionally placed a voxel in the posterior cortex to serve as a control. We predicted that, 
although GABA in this region would decline with age, there would be no association 
between GABA concentrations and global cognitive performance.
METHODS AND MATERIALS
Population
Ninety-four older volunteers (54 women, 40 men; age [mean ± SD], 73.12 ± 9.9 years; years 
of education, 16.25 ± 2.8 years; MoCA scores, 25.5 ± 2.5) were recruited from the local 
community. Subjects with a self-reported history of neurological or psychiatric disease on 
comprehensive medical questionnaires or magnetic resonance imaging (MRI) prescreening 
forms were excluded from the study. Subjects reported abstaining from alcohol on the day of 
MRS data collection. Of the 94 subjects, 89 had the frontal voxel collected, and 90 had the 
posterior voxel collected (due to time constraints in the imaging sequence, 5 participants had 
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only a frontal voxel collected and 4 participants had only a posterior voxel collected). 
Ethical approval for the study was obtained via the University of Florida’s Institutional 
Review Board, and all participants signed an informed consent form after discussion of the 
study with a study coordinator and review of the document.
MoCA
The MoCA is a one-page cognitive assessment that takes approximately 10 minutes to 
administer. A score of 0–30, reflecting general cognitive function, is derived from 
performance on tasks assessing the following cognitive domains: verbal memory, 
visuospatial abilities, executive functions, attention, working memory, naming, verbal 
fluency, repetition, and orientation to time and place (30). One point was added to the scores 
of participants who had 12 years of education or less (30). Using the MoCA total score in 
this analysis has a number of advantages. First, the MoCA is a widely used clinical tool with 
good psychometric properties (e.g., test-retest reliability and internal consistency). It has 
better sensitivity to mild cognitive impairment and other forms of cognitive decline, 
including Korsakoff’s syndrome, than the Mini-Mental State Examination (32). Thus, a 
comparison between MoCA performance and GABA concentration allows for a discussion 
of these mechanisms in a translational context. Precisely because this measure is both 
sensitive and quick to administer, the MoCA is an efficient test to use in the clinical space. 
This analysis, then, allows for extension of previous GABA studies to a highly clinically 
relevant tool. The MoCA, however, does present a notable disadvantage. This instrument is 
useful when interpreted as a whole, but is not as useful at the level of subscale analysis, 
because the domains frequently are probed with three to five questions. This small range 
limits variability, and in healthy populations, many domains experience a ceiling effect. 
Therefore, the utility of this instrument is somewhat limited to general cognitive 
performance.
MRS Acquisition and Analysis, 1H-MRS Spectroscopy, Spectrum Editing, and Volume-of-
Interest Refraction
All scanning was performed on a 3T Philips Achieva scanner (Philips Healthcare, Best, The 
Netherlands) using a 32-channel head coil. A T1-weighted anatomical image 
(magnetization-prepared rapid gradient-echo; repetition time/echo time = 8 ms/3.7 ms, 1-
mm3 isotropic voxels) was acquired for MRS voxel placement and segmentation. GABA-
edited MRS data were acquired using the MEGA-PRESS sequence (12). PRESS localization 
was achieved with minimum-phase amplitude-modulated excitation pulses (2-kHz 
bandwidth) and amplitude-modulated refocusing pulses (bandwidth, 1.3 kHz), as shown in 
Figure 3 of Mullins et al. (14). Editing was performed with 14-ms sinc-Gaussian pulses 
applied at 1.9 ppm in the on experiment and 7.46 ppm in the off experiment. This editing 
scheme co-edits approximately 50% macromolecules at 3 ppm, which are coupled to spins 
at 1.7 ppm also inverted by editing pulses. Therefore, all GABA values reported refer to 
GABA + macromolecules. Acquisition variables were repetition time/echo time of 2 s/68 
ms; 320 transients with on-off scans alternating every 2 transients; a 16-step phase cycle 
(with steps repeated for on and off); 2048 data points acquired at a spectral width of 2 kHz; 
and variable pulse power and optimized relaxation delays (VAPOR) water suppression (33). 
Sixteen transients of water-unsuppressed data were also acquired for quantification using the 
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same acquisition variables. All voxels were 3 × 3 × 3 cm3. Representative voxel locations 
are shown in Figure 1A. Voxel locations were verified after data collection to identify 
placement errors. Quantitative analysis was performed using the Gannet program (version 
2.0) (34). All time domain data were frequency- and phase-corrected using spectral 
registration (35), filtered with a 3-Hz exponential line broadening and zero-filled by a factor 
of 16. The 3-ppm GABA peak in the difference spectrum was fit using a five-parameter 
Gaussian model and quantified relative to water (fit with a Gaussian-Lorentzian model) in 
institutional units. To correct for tissue-related factors, controlling for cerebrospinal fluid 
(CSF) content in the voxel is the most common approach (36) and has been applied in 
populations in whom voxel tissue composition may vary (37,38). This correction involved 
the generation of a binary mask of the MRS voxel created with the same imaging matrix as 
the T1-weighted anatomical image, using Gannet’s (34) integrated voxel-to-image 
coregistration. Segmentation of the anatomical image was performed using Segment in 
SPM12 (39). The voxel fraction that was CSF, gray matter, and white matter was calculated. 
In addition, all multiple regression models were rerun, replacing CSF with gray matter and 
white mater in the model. In all models, all factors significant for the CSF approach were 
also significant for the gray matter and white matter approach and vice versa. Thus, we only 
report the CSF fraction because it makes fewer assumptions as to tissue-specific GABA 
concentrations (36) and is more consistent with previously published approaches to age-
related changes in GABA (7).
RESULTS
MoCA as a Function of Demographic Variables
MoCA scores were initially investigated with relation to the demographic variables. Multiple 
regression was used to analyze the predictive value of age and education for overall 
cognitive performance. This regression demonstrated that these demographic variables 
accounted for a significant proportion of variance in cognitive performance (R2 = .1103, 
F2,91 = 5.64, p < .005). Within this model, age significantly predicted score, such that older 
participants had lower scores (B = −.08, p < .005). Figure 2A displays the relation between 
age and MoCA score. Education was not associated with scores (B = .08, p = .33).
GABA Concentrations as a Function of Brain Region
A significant difference was found for GABA concentrations between the frontal (1.546 
± 0.305) and posterior (.7339 ± 0.264) voxels (t84 = −5.3373, p < .001), with a greater 
concentration of GABA in the posterior voxel.
GABA Concentrations as a Function of Age
Frontal Voxel—With the use of a linear regression model, lower GABA concentrations 
significantly predicted increased age (R2 = .25, F1,87 = 29.56, p < .001, B = −16.42, p < .
001). Given that this decrease may have been a function of age-associated atrophy, rather 
than GABA-specific changes per se, we conducted a multiple regression, including CSF 
fraction and GABA concentration as predictors of age (R2 = .38, F2,86 = 26.19, p < .001). 
CSF concentrations were positively associated with age (B = 57.41, p < .001), and GABA 
concentrations were negatively associated with age (B = −9.378, p < .01). Notably, even 
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when accounting for CSF fraction, GABA concentration remained a significant predictor of 
age. This association is depicted in Figure 2B.
Posterior Voxel—Linear regression revealed that lower GABA concentrations in the 
posterior voxel significantly predicted increased age (R2 = .15, F1,88 = 15.26, p < .005, B = 
−14.28, p < .001). To account for age-related atrophy, a multiple regression was conducted 
with CSF fraction and GABA concentration as predictors of age (R2 = .38, F2,86 = 26.19, p 
< .001). Greater age was related to lower GABA concentrations (B = −13.95, p < .01); no 
relation was found between CSF concentrations and age (B = 1.65, p = .93). This association 
is depicted in Figure 2C.
Cognitive Performance as a Function of GABA Concentrations
Frontal Voxel—The relation between frontal GABA concentration and the MoCA score 
was investigated using linear regression. The results of this regression indicated that GABA 
in this region accounted for a significant amount of variance in MoCA performance, such 
that higher concentrations of GABA predicted better cognitive functioning (R2 = .18, F1,87 = 
18.95, p < .001, B = 3.5, p < .001). On visual inspection, two data points appeared to be 
outliers. Although they did not fall beyond our outlier cutoff of 3 SDs above or below the 
mean, we reran the analyses without these participants. When their data were removed, the 
relation remained significant (R2 = .12, F1,85 = 11.63, p < .001), and GABA concentration 
continued to predict cognitive functioning (B = 3.3, p < .001).
Next, the relation between GABA concentration and MoCA score was queried, controlling 
for age, education, and CSF fraction. The results of this multiple regression demonstrated 
that the four predictors accounted for a significant amount of the variance in cognitive 
performance (R2 = .22, F4,84 = 5.775, p < .001). Within this model, higher GABA 
concentration significantly predicted better score, even when accounting for demographic 
influences and CSF fraction (B = 3.32, p < .01). Cognitive performance was not 
independently related to age, years of education, and/or CSF fraction (B = −.5, p = .12; B = .
10, p = .24; B = 3.95, p = .37, respectively). We additionally reran the analyses without the 
two high-GABA participants. The overall model remained significant (R2 = .16, F4,82 = 
3.87, p < .01). Higher GABA concentration continued to predict better MoCA scores (B = 
3.14, p < .01), whereas the other covariates did not (B = −.5, p = .12; B = .10, p = .27; B = 
3.85, p = .39, respectively). Figure 2D depicts the association between frontal GABA 
concentration and MoCA, controlling for age, education, and CSF fraction.
Posterior Voxel—The relation between posterior GABA concentration and MoCA score 
was investigated using a linear regression. The results of this regression indicated that 
posterior GABA concentration does not account for a significant amount of variance in 
performance (R2 = .04, F1,88 = 5.267, p = .07). Next, the relation between posterior GABA 
concentration and MoCA score was queried, controlling for age, education, and CSF 
fraction. The results of this multiple regression demonstrated that the four predictors 
accounted for a significant amount of variance in cognitive performance (R2 = .12, F4,85 = 
2.84, p < .05). Among these variables, age was a significant predictor of cognitive 
performance (B = −.08, p < .01), such that greater age was associated with reduced 
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performance. GABA concentration, years of education, and CSF fraction did not 
significantly predict cognitive performance (B = 1.4, p = .34; B = .07, p > .44; B = 3.44, p 
= .48, respectively). The addition of age, education, and CSF fraction reduced the 
contribution to the model of the posterior GABA concentration.
DISCUSSION
The primary findings of our study are that GABA concentrations in frontal and posterior 
regions decline with age and that decline in frontal, but not posterior, GABA concentration 
was associated with lower MoCA scores. The finding of reduced GABA in frontal and 
posterior cortices is consistent with previous work that has used 1H-MRS to assess GABA in 
healthy adult populations (7), and it extends these findings by showing that this effect 
continues to occur with advanced age. Notably, the more aggressive rate of decline in frontal 
GABA concentrations is consistent with age-associated declines observed in other 
neuroimaging methods, including cortical volume (40) and white matter integrity (41,42), as 
well as with cognitive measures (43–45). Because a decline in GABA in the frontal region 
was evident even after controlling for atrophy by including CSF voxel fraction, we conclude 
that this effect is not simply a function of cortical atrophy, but rather a reduction of GABA 
concentration in brain tissue.
The age-related decline in GABA concentrations we report here is consistent with those 
previously reported by Gao et al. (7) in both frontal and posterior regions; however, other 
factors could account for the relation between GABA concentrations and MoCA scores. As 
such, we controlled for what were likely the strongest contributors: age and CSF fraction. 
Years of education was also included in the model because higher educational attainment is 
associated with superior cognitive function in old age in general (46) and on the MoCA 
specifically (30). Lower GABA concentrations, controlling for age, CSF fraction, and 
education, corresponded with lower MoCA scores in the frontal but not posterior voxel. 
Importantly, a one-unit increase in GABA corresponded to more than three-point increase in 
the MoCA score (B = 3.32), which is greater than estimates of test-retest reliability in the 
measure (30). Although the data presented here do not represent within-subject change, they 
suggest that a one-unit decrease in GABA would correspond to clinically significant 
cognitive decline. Given the small effect size, however, it should be contextualized as merely 
one factor contributing to age-related cognitive change. Other considerations influencing this 
relation are targets for future study and are further elucidated below.
Previous work has identified several specific cognitive domains that are associated with 
GABA concentration, including memory and attention (9,10,47). This investigation extends 
work on those specific domains to identify a connection between GABA and higher-order 
cognitive performance. Notably, although the MoCA is not designed for subdomain analysis, 
it is composed of a number of subtests tapping frontoexecutive functions. Given the 
significant GABA-cognition relation in the frontal but not posterior voxel, our results 
demonstrate some regional specificity of the impact of GABA concentration on cognition. 
Mechanistically, this relation may be subserved by the effect of GABA on signal-to-noise 
ratios in the implicated cortical regions. By increasing signal to noise, GABA likely 
facilitates information extraction and retention, abilities that are reflected in the total MoCA.
Porges et al. Page 7













A number of questions remain unresolved with respect to GABA and cognition in the 
context of aging. Although we controlled for age, education, and atrophy as measured by the 
percentage of CSF brain tissue, it is possible that other factors contribute to the observed 
associations. That is, although the present study demonstrates an overall association between 
age, GABA, and cognition, it lacks sufficient power to explore all possible covariates that 
contribute to this association. Potential mechanisms that may underlie our findings and that 
cannot be ruled out include changes in macromolecule concentrations and gray or white 
matter alterations beyond the sensitivity of the relatively coarse measure used here. For 
example, white matter integrity, as reflected by frontal scalar measures of anisotropy on 
diffusion MRI, may be a contributing factor. Indeed, age-related white matter changes may, 
to some extent, account for both the relation between age and cognition and the relation 
between GABA and cognition. Although we may have obliquely been able to address these 
changes by controlling for medical and/or behavioral comorbidities, this question would be 
more accurately addressed with a specific and intentional quantification of white matter 
changes. Therefore, future studies examining the relation between other neuroimaging 
methods such as diffusion MRI and GABA MRS would be valuable.
In addition, the present study queried potential comorbidities, including drug and alcohol 
abuse, through an extensive medical interview. However, we did not conduct toxicology 
screens on the participants to verify their statements, which may affect the generalizability 
of the results. Further studies specifically investigating the relation between GABA, age, 
cognition, and drug and alcohol use should use such an objective measurement. The relation 
between other comorbid factors that affect cortical GABA concentrations, such as insomnia 
and depression (48,49) and their interaction with aging, should also be investigated because 
these may modulate the relation between GABA and cognition.
Finally, the mechanisms underlying the influence of GABA on cognitive performance need 
to be investigated in greater detail. Decreases in GABA concentrations may indicate 
alterations in interneuron population or function, and these facilitator systems for neuronal 
communication may be sensitive to subclinical variations in brain health and function (e.g., 
neuroinflammatory factors or baseline and reactive shifts in autonomic nervous system 
mobilization). Although beyond the scope of the present study, additional research exploring 
the mechanisms of decline in GABA concentrations during normal aging and associated 
cognitive consequences would be beneficial. Results of the present investigation may have 
important clinical implications. Given the relation between GABA concentrations and 
cognitive function, it may be fruitful to explore the longitudinal trajectory of GABA and 
cognitive decline in the context of mild cognitive impairment and Alzheimer’s disease. 
Furthermore, decline in frontal GABA concentrations may serve as both a predictor of 
neurodegenerative disease and an opportunity for pharmacological intervention. Future 
work, then, should establish the reliability of the relation between GABA and cognitive 
function in healthy older adults and examine it in clinical populations as well.
In summary, we demonstrate that the previously reported age-related decrease in GABA (7) 
continues into later life. Furthermore, we introduce evidence that frontal concentrations of 
GABA are predictive of general cognitive function in an aging population, even when 
controlling for well-known predicators of cognitive function, such as age, education, and 
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brain atrophy. Future research will be well served to investigate tissue-specific 
concentrations of GABA and their relation to cognitive function to facilitate 
pharmacological or other intervention approaches.
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(A) Voxel locations in the frontal and posterior regions of the brain. The gray box represents 
the location of the 3 × 3 × 3 cm voxel collected using Mescher-Garwood point-resolved 
spectroscopy. (B) Edited spectra from the frontal and posterior voxels for all subjects. 
Gamma-aminobutyric acid (GABA) peak is at 3.02 ppm. (C) Representative Gannet GABA 
model fit. (D) Stacked dot plot demonstrating greater GABA concentrations in the posterior 
voxel. I.U., institutional unit.
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Confidence intervals are 95% for the regression line. (A) Plot demonstrating greater 
participant age associated with lower performance on the Montreal Cognitive Assessment 
(MoCA). (B) Plot demonstrating the age-related decrease in frontal gamma-aminobutyric 
acid (GABA) concentrations. (C) Plot demonstrating the age-related decrease in posterior 
GABA concentrations. (D) Plot demonstrating the relation between frontal GABA 
concentrations and MoCA scores. The relation remains significant when the two highest 
GABA data points are removed. CSF, cerebrospinal fluid.
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